The Alzheimer's Association and National Institutes of Health have emphasized the need for participation of racial/ethnic populations in Alzheimer disease (AD) clinical research. Many articles have described strategies to enhance participation including establishing enduring ties to the community and tailoring the site to be more culturally welcoming or user-friendly to the community. Yet, most of these reports are not data driven. To get a better indication of the knowledge base, this review summarizes research across a broad range of domains (e.g., cancer, kidney disease, AD) that used systematic approaches to identify methods and factors that reduce barriers to recruitment, participation, and retention of a more racially and ethnically diverse population. Overall, 121 reports were found with 8 of these in AD. As a relatively new area of investigation, the literature was primarily descriptive; outcome data were seldom provided. While these studies help to identify areas of potential importance in racial/ethnic participation, hypothesis-driven research remains necessary to tease apart the key techniques that engender racial/ethnic participation in AD studies. This article suggests several recommendations, including the need for prospective research of specific recruitment methods. Fundamentally, researchers should consider that these strategies apply to all potential research participants, and not simply to traditionally underserved racial/ethnic populations.
Enrollment of racial/ethnic populations into Alzheimer disease (AD) clinical trials and clinical care centers does not reflect the population at large; approximately 95% of subjects enrolled in clinical trials are white. Of the participants in four NIA-funded Alzheimer's Disease Cooperative Study trials, about 6% were African American individuals and 4% were Hispanic individuals (Sano, 2000) . An international database of clinical trials of the cholinesterase inhibitor, donepezil, reported that of the 4,301 participants, 2.4% were African American individuals and 0.9% were Hispanic individuals (McCrae, 2000) .
There are some obvious reasons for lower participation rates. Schneider et al. (1997) , applying industrysponsored clinical trials entry criteria to a large AD patient registry, noted that the criteria preferentially selected wealthier, more educated, and white individuals. A significant proportion of the current cohort of older adults who are Hispanic with AD are not fluent in English . Yet, many clinical trial sites lack Spanish-speaking staff, and many clinical trials lack materials in Spanish.
The need to increase representation of racial/ethnic populations in clinical research is obvious. In Los Angeles County, California, for example, 2000 census estimates showed that although whites were the most common residents, they were no longer the majority (48.7%). Of the estimated 110,000 persons in the county with a dementing illness, 30-35% currently belong to a racial/ethnic group. Census estimates show that Hispanics are the fastest growing group of racial/ethnic elderly.
Greater participation of racial/ethnic groups in clinical research potentially has numerous obvious advantages to these underserved groups, including better access to medical care, treatment of dementia symptoms, and added support for relatives. For the research community, having other racial/ethnic groups participating in research help to reduce and explain the heterogeneity of AD, where course and treatment response may vary by race and ethnicity. If there are differences in treatment response based on race and ethnicity, sufficiently large samples of subjects are needed to identify these effects.
Clinical sites that are interested in increasing participation rates of racial/ethnic populations can find numerous research reports that provide guidance. However, most of these reports are descriptive in nature, including the frequently cited review of Swanson and Ward (1995) . For clinical research to make lasting gains, empirical approaches are needed to validate these methods, given that they have the potential to enhance participation to all potential subjects.
METHODS
The goal of this analysis was to identify articles that systematically applied methods related to recruitment, participation, and retention of racial/ethnic groups in clinical research, and not solely psychiatry. A broad search was performed because few studies have been performed.
Articles were acquired from three sources. First, we examined the articles cited in the seminal review of Swanson and Ward (1995) . This yielded 107 reports. Note that some of these reports were opinion papers, discussion articles, and news pieces.
Articles published between 1995-1998 were identified through a search of the following databases: MEDLINE, CancerLit, and AIDSLINE. The following search terms were used in combination: (1) minority, race, racial, ethnic group, Asian Americans, African Americans, Blacks, Hispanic Americans, Indians (Central American, South American, and North American); and (2) clinical trials, patient selection, randomized controlled trials, accrual, recruitment. This yielded 288 articles. Finally, an inspection of references identified eight articles.
Of the 403 articles, articles were selected that were related to the participation of racial/ethnic participants in research, and provided either (a) a quantitative analysis of the methods, or (b) a detailed description of the methods. Articles that were excluded included news reports, opinion articles, discussion articles, and literature reviews.
RESULTS

Current Literature
One hundred twenty-one reports were identified, published between 1984-1998 that have examined recruitment, enrollment, and participation of racial/ethnic populations in research studies. There were 90 articles and 31 abstracts. The articles were further divided into three groups: (1) articles that provided a quantitative analysis of the methods (n ‫ס‬ 47); (2) surveys, questionnaires, or focus groups (n ‫ס‬ 33); and articles that clearly described methods but lacked analysis of the effects (n ‫ס‬ 41). The mean sample size was 1,142 subjects (SD ‫ס‬ 2,641) and the mean age was 51.4 years (SD ‫ס‬ 15.3). Twenty-six percent of the findings were derived from community interviews; 24% were from clinical trials. Twenty-six percent of the articles were in studies of HIV, 26% were in studies of cancer; 6% focused specifically on AD or aging, with six providing data. In the articles that described the participants' race or ethnicity, the majority focused on African Americans (62%).
The articles were further divided into three descriptive themes based on their content and are summarized below.
Targeted Subject Identification
Identifying potential ethnic participants can be challenging, and some researchers have relied on census data and telephone books to find them. Six reports examined methods of gaining lists of potential ethnic participants based on targeting surnames. Three of these reported good sensitivity at identifying people of Hispanic origin based on surnames, but poor positive predictive power when surnames were used alone (due to Filipino participants having similar surnames). Those that used additional information, such as surnames of parents and parental birthplace were more successful. Whether families that are identified using these methods can then become participants in AD studies has not been evaluated.
Community Involvement
It may seem axiomatic that community involvement is a prerequisite for successful racial/ethnic participation.
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Twenty-seven articles made use of this method, but findings were equivocal. For example, all of the reports that recommended investigators solicit community advice in the planning stages of a study provided no outcome data. The two reports that suggested local health service providers should be closely linked to the investigators had contradictory findings, with one study showing an increased benefit and the other showing none. Many articles described the need to link community agencies to the researchers, but only two articles provided outcome data, and neither compared community involvement to a noninvolvement condition. Eight studies recommended that educating the community leads to greater participation, and only one report provided data. This group attributed increased enrollment over a threeyear period to this factor, without providing a comparison to any other method.
Increasing the level of personal contact between the investigators and racial/ethnic participants was generally reported as beneficial, and 13 articles provided data to substantiate this claim. Some sites found that using a secondary agency (e.g., community clinic) that already had a personalized connection with the potential participants showed better success than mass mailings or mass media. Yet, six articles reported the opposite, with some stating that mass media methods were five times more likely to result in recruitment than direct contact meetings in the community.
Logistical Issues
Numerous articles commented on logistical issues that can affect participation, including having an on-site clinic, the need for stipends, transportation, childcare, or meals. The majority of these reports were generated from surveys of investigators, participants, and community members; thus, specific interventions have yet to be formally tested. For example, the articles that mentioned the need for flexible appointment scheduling did not identify what additional level of flexibility is needed compared with non-racial/ethnic participants.
Staff Qualities
Many articles suggested the need for culturally competent/ bilingual staff as an enhancement to participation, and two provided numeric data. In one case, the investigators found that culturally trained physicians recruited racial/ethnic participants to the same proportion as that in the community. However, they did not compare their method using untrained physicians. The other report found no influence of recruiter race/ethnicity on participation rates.
DISCUSSION
Overall, this review found little empirically based literature examining racial/ethnic participation issues, particularly in AD. Although these articles are helpful in identifying potential directions for increasing racial/ethnic involvement, they do not directly assess the efficacy of their findings.
Numerous reports have addressed racial/ethnic participation in research studies. Most provide recommendations to enhance participation. However, the current literature is primarily descriptive, lacking hypotheses and experimental methods. Overall, the articles suggest the need for researchers to be more culturally connected to the racial/ethnic targeted community, but there are few data to support these conclusions, and in some cases it is contradictory. It is time for researchers to approach racial/ethnic population participation in a more systematic manner.
Here are recommendations for future research:
1. Prospectively test specific elements of the program before it is successful and in place. This will allow others to identify which elements are most necessary. 2. Cross-validate programs with different racial/ethnic populations and in different geographic areas. For example, it is possible that these methods apply to all potential participants, not mere those from traditionally underserved racial/ethnic communities. Without broad sampling, stereotyping of ethnic/racial groups might occur. 3. Identify the level of personal contact that is minimally needed, and whether this differs from nonracial/ethnic participants. Knowing the minimal threshold will likely ensure that researchers are spending enough time, given that most sites likely do not meet this level of attention. In addition, it may be that this threshold is the same for participants, regardless of ethnic/racial background. 4. Determine the extent that staff or investigators need to be culturally linked to the population. Cultural competency and cultural linkages are almost always recommended, but are not well studied. 5. Validate barriers and issues that have been identified through the use of community and expert surveys. For example, surveys typically mention that participants must be educated about the study, but the degree of added education has not been assessed. 6. Determine costs for implementation of these methods, and compare those costs to recruitment of nonracial/ethnic participants. It is important to include the investment already made in the non-racial/ethnic community and quantify it to have an honest comparison.
By having a better estimate of costs for engagement of non-ethnic/racial communities as well as racial/ethnic communities, researchers will be more likely to meet participation goals. Presumably, many researchers continue to devote too few resources to participation in general and specifically to participation of communities to which the researcher does not belong.
Although this report focused on increasing participation of racial/ethnic participants, it is likely that these methods apply to most potential participants, not merely those from historically underserved racial/ethnic backgrounds. In addition, this article does not discuss largerscale themes, such as the overall motivation of the research investigators. For example, a significant amount of clinical research is carried out by the use of a clinical research organization (CRO) to provide supervision and management of a clinical trial. Yet, this may create an added barrier if the researchers have not engendered a commitment from the CRO to including racial/ethnic participants. Unlike NIH research, there are no laws that require privately funded research to have representative populations in their studies. It is hoped that researchers in AD remain concerned for the adequate representation of our nation's diverse population.
